2016 - Webinar on FDA Quality Metrics and Risk Based Inspections
Date2016-03-08
Deadline2016-03-08
VenueMississauga, Canada
KeywordsFDA Quality Metrics; Risk Based Inspections; FDA Warning Letters
Topics/Call fo Papers
Description :
This live training webinar will discuss the just issued (July 2015) DRAFT Guidance for Industry on “Request for Quality Metrics” along with how FDASIA is pushing it forward, review the most common Citations issued during the past several years, dissect each resultant Observation, explain the rationale behind them and present actual examples of Form FDA 483s and Warning Letters that include that particular Observation. A total of approximately 15 sections within CDER’s CFRs from each year will be examined in detail and their frequency compared against previous years.
This webinar is especially valuable to not only those within the Quality area of your Company, but also within other Departments to include Incoming Raw Materials, Manufacturing and Facilities. Because of the sensitivity and importance of understanding Quality Metrics, this live training webinar is a MUST for anyone in your organization that is involved in the management of, or recipients of Regulatory actions.
Areas Covered in the Session :
Introduction
Human Drug Establishment Inclusion & Expectations
Quality Metrics Background
Process Validation and Quality Metrics
The Use of Quality Metrics
Effects of Non-Reporting
Reporting of Quality Metrics
Review of Pertinent Form FDA 483s and Warning Letters
Summary
Who Will Benefit:
Quality Assurance Teams
Quality Control Teams
Research & Development Teams
Manufacturing Teams
Regulatory Affairs Departments
Scientists
Pharmaceutical Manufacturers
Contract Laboratories
API Manufacturers
Device Manufacturers
For more information and enquiries contact us at
Compliance Trainings
5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada
Customer Support : #416-915-4458
Email : support-AT-compliancetrainings.com
For more information about this event please visit
https://compliancetrainings.com/SiteEngine/Product...
This live training webinar will discuss the just issued (July 2015) DRAFT Guidance for Industry on “Request for Quality Metrics” along with how FDASIA is pushing it forward, review the most common Citations issued during the past several years, dissect each resultant Observation, explain the rationale behind them and present actual examples of Form FDA 483s and Warning Letters that include that particular Observation. A total of approximately 15 sections within CDER’s CFRs from each year will be examined in detail and their frequency compared against previous years.
This webinar is especially valuable to not only those within the Quality area of your Company, but also within other Departments to include Incoming Raw Materials, Manufacturing and Facilities. Because of the sensitivity and importance of understanding Quality Metrics, this live training webinar is a MUST for anyone in your organization that is involved in the management of, or recipients of Regulatory actions.
Areas Covered in the Session :
Introduction
Human Drug Establishment Inclusion & Expectations
Quality Metrics Background
Process Validation and Quality Metrics
The Use of Quality Metrics
Effects of Non-Reporting
Reporting of Quality Metrics
Review of Pertinent Form FDA 483s and Warning Letters
Summary
Who Will Benefit:
Quality Assurance Teams
Quality Control Teams
Research & Development Teams
Manufacturing Teams
Regulatory Affairs Departments
Scientists
Pharmaceutical Manufacturers
Contract Laboratories
API Manufacturers
Device Manufacturers
For more information and enquiries contact us at
Compliance Trainings
5939 Candlebrook Ct, Mississauga, ON L5V 2V5, Canada
Customer Support : #416-915-4458
Email : support-AT-compliancetrainings.com
For more information about this event please visit
https://compliancetrainings.com/SiteEngine/Product...
Other CFPs
- Webinar on ASQ Certified Quality Engineer (CQE) Exam Preparatory Course - Webinar Series
- Webinar on Interviewing Strategies: Essential Skills for Supervisors
- Webinar On Complaint Management in Accordance with 21 CFR, Part 820.198
- Webinar On Toyota Kata - Wax On, Wax Off (in partnership with ASQ Lean Enterprise Division)
- Regulatory Requirements for Over-the-Counter (OTC) Drug Products
Last modified: 2016-02-25 21:24:44